Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism.

作者信息

Maitland-van der Zee Anke-Hilse, Klungel Olaf H, Leufkens Hubertus G M, de Boer Anthonius, Stricker Bruno H Ch, Hofman Albert, Witteman Jacqueline C M, van Duijn Cornelia M, Kastelein John J P

出版信息

Atherosclerosis. 2004 Aug;175(2):377-9. doi: 10.1016/j.atherosclerosis.2004.04.009.

DOI:10.1016/j.atherosclerosis.2004.04.009

PMID:15262195

Abstract

摘要

相似文献

Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism.

Atherosclerosis. 2004 Aug;175(2):377-9. doi: 10.1016/j.atherosclerosis.2004.04.009.

ACE insertion deletion polymorphisms and effectiveness of statin therapy.

Atherosclerosis. 2005 Feb;178(2):405. doi: 10.1016/j.atherosclerosis.2004.10.003.

DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: the PREFACE trial.

Heart. 2003 May;89(5):557-8. doi: 10.1136/heart.89.5.557.

Deletion/insertion polymorphism in the angiotension-converting enzyme gene as a risk factor in the Slovenian patients with coronary heart disease.

Pflugers Arch. 2000;439(3 Suppl):R40-1.

Deletion polymorphism of the angiotensin I-converting enzyme gene in elderly patients with coronary heart disease.

Coll Antropol. 2007 Mar;31(1):179-83.

[Relation between coronary artery disease and polymorphism of angiotensin converting enzyme gene].

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2002 Jan;19(1):105-7.

The angiotensin-converting enzyme gene insertion/deletion polymorphism and effects of quinapril and atorvastatin on haemostatic parameters in patients with coronary artery disease.

Thromb Haemost. 2005 Jul;94(1):224-5.

ACE gene polymorphism and coronary restenosis.

Semin Interv Cardiol. 1999 Sep;4(3):145-9. doi: 10.1053/siic.1999.0085.

Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study.

Eur Heart J. 1999 Sep;20(18):1318-25. doi: 10.1053/euhj.1999.1543.

Insertion/deletion polymorphism of angiotensin-converting enzyme gene--risk factor for coronary artery disease in the Tuzla region population (Bosnia and Herzegovina).

Coll Antropol. 2003 Dec;27(2):537-40.

引用本文的文献

Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia.

Pharmacoeconomics. 2013 May;31(5):377-91. doi: 10.1007/s40273-013-0045-6.

Pharmacogenetics of cardiovascular drug therapy.

Clin Cases Miner Bone Metab. 2009 Jan;6(1):55-65.

ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation.

BMC Med Genet. 2009 Jun 4;10:50. doi: 10.1186/1471-2350-10-50.

ACE genotype, risk and causal relationship to stroke: implications for treatment.

Curr Treat Options Cardiovasc Med. 2007 Jun;9(3):198-204. doi: 10.1007/s11936-007-0013-6.

Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study.

Am Heart J. 2007 Jan;153(1):54-8. doi: 10.1016/j.ahj.2006.10.019.

Pharmacogenetics of response to statins: where do we stand?

Curr Atheroscler Rep. 2005 May;7(3):204-8. doi: 10.1007/s11883-005-0007-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验